Pharmafile Logo
Pharmafocus logo
Advanced Search

Pfizer heart drug gains new licence in UK

April 5, 2012
Sales and Marketing Inspra, NHS, Pfizer, heart failure

Pfizer’s heart pill Inspra has gained a new licence in the UK to reduce the risk of death in patients …

News
Diabetes nest image

Roche sponsors Twitter-based diabetes community

April 5, 2012
Medical Communications Ignite Health, Roche, Twitter, diabetes

Roche is to sponsor a Twitter-based site devoted talk about diabetes, furthering its close links with online commentators.  ‘Diabetes Nest’ …

News
Brain image

The brain drain

April 5, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, R&D, brain drain, research and development

Concerns about the growing number of companies disinvesting from neuroscience research have been growing in recent years, and the latest …

Feature

Eric Abadie resigns as chair of the CHMP

April 5, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CHMP, Eric Abadie

Dr Eric Abadie has told the European Medicines Agency that he is resigning as chair of the Committee for Medicinal …

Appointment

FDA grants priority review for Sanofi cancer drug

April 5, 2012
Research and Development, Sales and Marketing Erbitux, FDA, Regeneron, Sanofi, Zaltrap, colorectal cancer, prostate cancer

The FDA has granted Sanofi and partner Regeneron priority review for their colorectal cancer drug Zaltrap. Zaltrap (aflibercept) is seeking a …

News

Drugmakers ‘premature’ in requests for metal impurity data

April 5, 2012
Manufacturing and Production ICH, manufacturing, metal impurity

Pharmaceutical manufacturers are acting ‘prematurely’ when asking excipient suppliers to provide metal impurity levels, according to a new position paper …

News
Lonza picture

Lonza names Ridinger as new chief executive

April 5, 2012
Manufacturing and Production Cognis, Lonza, Ridinger

Swiss contract manufacturer and ingredients supplier Lonza has appointed Richard Ridinger as its new chief executive, replacing Stefan Borgas who …

News

AstraZeneca signs respiratory pact with Amgen

April 5, 2012
Research and Development Amgen, AstraZeneca, MedImmune, respiratory

AstraZeneca has bought its way into Amgen’s inflammation portfolio with a $50 million upfront payment to co-develop and commercialise five …

News

Orphan Medicinal Products in the EU- Free Webinar

April 4, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Orphan Medicinal Products in the EU: Eligibility, Orphan Designation and IncentivesThe structure of this webinar is:Introduction: Legislative Basis and Criteria …

News
Press release

NHS spending on drugs fell in 2011

April 4, 2012
Sales and Marketing NHS, cost savings, generic, patent, prescriptions, spend

The NHS in England spent less on its drugs budget last year, bucking the longstanding upward trend. This is because …

News
GSK image

GSK’s diabetes drug misses goal

April 4, 2012
Research and Development, Sales and Marketing Bydureon, GSK, Victoza, albiglutide, diabetes

GlaxoSmithKline has insisted its new long-acting Type 2 diabetes drug albiglutide remains on course for filing following topline results from …

News

EMG appoints two new senior members

April 4, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing EMG, Matthew Speers, Steve Turley, UCB

A new chair and vice-chair have been appointed to lead the European Medicines Group (EMG).   EMG is the voice of …

Appointment

Glyn Edwards appointed as chief executive of Summit

April 4, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Glyn Edwards, summit

Summit, a UK drug discovery company, has appointed Glyn Edwards as its new chief executive. Edwards will take up the …

Appointment

EMA creates new conflict of interest rules

April 4, 2012
Sales and Marketing EMA, Lonngren, conflict of interest

The European Medicines Agency has introduced new rules to tighten up conflicts of interest, and have less reliance on pharma …

News

New Europe-wide approach for the classification of commercially confidential information and personal data in MAAs

April 3, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The Heads of Medicines Agencies(HMA) and the European Medicines Agency (EMA) have adopted a joint guidance document, providing a consistent …

News
Press release

Catalent Extends Development and Analytical Solutions Capabilities in Swindon, UK

April 3, 2012
Research and Development

Somerset, NJ – March 22, 2012 — Catalent Pharma Solutions today announces the completion of new Development and Analytical Solutions’ …

News
Press release
Bayer image

Bayer cancer drug meets Phase III goal

April 3, 2012
Research and Development, Sales and Marketing Bayer, Cancer, Glivec, Novartis, phase III, regorafenib

Bayer’s stomach cancer pill regorafenib has significantly improved progression free survival in late-stage patients. Results from the Phase III trial …

News

Life appoints new digital developer

April 3, 2012
Business Services, Medical Communications, Sales and Marketing Life, Nick Douglas

Life Healthcare Communications has created a new digital developer role, continuing the growth of its digital department.  The firm has …

Appointment

Standardised equipment and centralised spirometry for optimal data quality

April 3, 2012
Research and Development

IntroductionWhen developing the treatments for asthma and COPD, pharmaceutical companies utilise pulmonary function testing (PFT) to determine each compound’s efficacy. …

Feature
Thought Leadership

Considerations with dual site production

April 3, 2012
Research and Development

There are generally two options available when looking to expand storage capacity – build to develop existing facilities or select …

Feature
Thought Leadership
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026